Human Leukocyte Antigen and Aseptic Loosening in Charnley Total Hip Arthroplasty

Clinical Orthopaedics and Related Research

Volumn 413, Issue , 2003, Pages 183-191

  Takayanagi, Satoshi ^a   Nagase, Mitsuo ^a   Shimizu, Toru ^b   Kobayashi, Toshihiko ^a   Shirakura, Kenji ^a   Takagishi, Kenji ^a  

^a GUNMA UNIVERSITY   (Japan)

^b Ken o Hospital   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; HLA A ANTIGEN; HLA ANTIGEN; HLA B ANTIGEN; HLA C ANTIGEN; HLA DP ANTIGEN; HLA DQ ANTIGEN; HLA DR ANTIGEN; T LYMPHOCYTE RECEPTOR;

ADULT; ARTICLE; CHARNLEY LOW FRICTION ARTHROPLASTY; ENDOPROSTHESIS LOOSENING; FEMALE; HIP ARTHROPLASTY; HIP PROSTHESIS; HIP RADIOGRAPHY; HLA SYSTEM; HUMAN; IMMUNE RESPONSE; IMPLANT; MAJOR CLINICAL STUDY; MALE; PHENOTYPE; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; TOTAL HIP PROSTHESIS; HAPLOTYPE; MIDDLE AGED; PROSTHESIS FAILURE;

ADULT; ARTHROPLASTY, REPLACEMENT, HIP; FEMALE; HAPLOTYPES; HIP PROSTHESIS; HLA ANTIGENS; HLA-A ANTIGENS; HLA-B ANTIGENS; HLA-C ANTIGENS; HLA-DQ ANTIGENS; HLA-DR ANTIGENS; HUMANS; MALE; MIDDLE AGED; PROSTHESIS FAILURE;

EID: 0042977691     PISSN: 0009921X     EISSN: 15281132     Source Type: Journal    
DOI: 10.1097/01.blo.0000073340.50837.d8     Document Type: Article

References (54)

1. Aspenberg P, Van Der Vis H: Fluid pressure may cause periprosthetic osteolysis. Acta Orthop Scand 69:14, 1998.
2. Brander C, Mauri-Hellweg D, Bettens F, et al: Heterogenous T cell responses to b-lactom modified self structures are observed in penicillin allergic individuals. J Immunol 155:2670-2678, 1995.
3. Bodmer WF, Albert E, Bodmer JG, et al: Nomenclature for factors of the HLA system, 1987. Hum Immunol 26:3-14, 1989.
4. Charnley J, Cupic Z: The nine and ten year results of the low-friction arthroplasty of the hip. Clin Orthop 95:9-25, 1973.
5. Crowe JF, Mani VJ, Ranawat CS: Total hip replacement in congenital dislocation and dysplasia of the hip. J Bone Joint Surg 61A:15-23, 1979.
6. Engh Jr CA, Culpepper II WJ, Engh CA: Long-term results of use of the anatomic medullary locking prosthesis in total hip arthroplasty. J Bone Joint Surg 79A:177-184, 1997.
7. Goldring SR, Schiller AL, Roelke M, et al: The synovial-like membrane at the bone-cement interface in loose total hip replacements and its proposed role in bone lysis. J Bone Joint Surg 65A:575-584, 1983.
8. Haddad FS, Cobb AG, Bentley G, et al: Hypersensitivity in aseptic loosening of total hip replacements. J Bone Joint Surg 78B:546-549, 1996.
9. Harris WH: Osteolysis and particle disease in total hip replacement. Acta Orthop Scand 65:113-123, 1994.
10. Harris WH: The problem is osteolysis. Clin Orthop 311:46-63, 1995.
11. Harris WH, McCarthy Jr JC, O'Neill DA: Femoral component loosening contemporary techniques of femoral cement fixation. J Bone Joint Surg 64A:1063-1067, 1982.
12. Harris WH, McGann WA: Loosening of the femoral component after use of the medullary-plug cementing technique. J Bone Joint Surg 68A:1064-1066, 1986.
13. Hicks DG, Judkins AR, Sickel JZ, et al: Granular histiocytosis of pelvic lymph nodes following total hip arthroplasty. J Bone Joint Surg 78A:482-496, 1996.
14. Hodgkinson JP, Shelley P, Wroblewski BM: The correlation between the roentgenographic appearance and operative findings at the bone-cement junction of the socket in Charnley low friction arthroplasties. Clin Orthop 228:105-109, 1988.
15. Horowitz SM, Purdon MA: Mediator interactions in macrophage/particulate bone resorption. J Biomed Mater Res 29:477-484, 1995.
16. Howie DW, Haynes DR, Rogers SD, et al: The response to particulate debris. Orthop Clin North Am 24:571-581, 1993.
17. Imanishi T, Akaza T, Kimura A, Tokunaga K, Gojobori T: Allele and Haplotype Frequencies for HLA and Complement Loci in Various Ethnic Groups. In Tsuji K, Aizawa M, Sasazuki T (eds). HLA 1991. Tokyo, Oxford University Press 1065-1074, 1992.
18. Jacobsson SA, Djerf K, Wahlström O: 20-year results of McKee-Farrar versus Charnley prosthesis. Clin Orthop 329(Suppl):S60-S68, 1996.
19. Jiranek W, Jasty M, Wang JT, et al: Tissue response to particulate polymethylmethacrylate in mice with various immune deficiencies. J Bone Joint Surg 77A:1650-1661, 1995.
20. Johnston RC, Brand RA, Crowninshield RD: Reconstruction of the hip. J Bone Joint Surg 61A:639-652, 1979.
21. Kaspenberg ML, Wierenga EA, Stiekema FEM, et al: Th1 lymphokine production profiles of nickelspecific CD4+ lymphocyte clones from nickel contact allergic and non-allergic individuals. J Invest Dermatol 98:59-63, 1991.
22. Kavanagh BF, Dewitz MA, Ilstrup DM, et al: Charnley total hip arthroplasty with cement. J Bone Joint Surg 71A:1496-1503, 1989.
23. Kim KJ, Chiba J, Rubash HE: In vivo and in vitro analysis of membranes from hip prosthesis inserted without cement. J Bone Joint Surg 76A:172-180, 1994.
24. Kobayashi S, Takaoka K, Saito N, et al: Factors affecting aseptic failure of fixation after primary Charnley total hip arthroplasty. J Bone Joint Surg 79A:1618-1627, 1997.
25. MacKenzie JR, Kelley SS, Johnston RC: Total hip replacement for coxarthrosis secondary to congenital dysplasia and dislocation of the hip. J Bone Joint Surg 78A:55-61, 1996.
26. Maloney WJ, Smith RL: Periprosthetic osteolysis in total hip arthroplasty: The role of particulate wear debris. J Bone Joint Surg 77A:1448-1461, 1995.
27. Mauri-Hellweg D, Bettens F, Mauri D, et al: Activation of dr-ug-specific CD4+ and CD8+ T cells in individuals allergic to sulfonamides, phenytoin and carbamazepine. J Immunol 155:462-472, 1995.
28. Mulroy WFF, Estok DM, Harris WH: Total hip arthroplasty with use of so-called second-generation cementing techniques. J Bone Joint Surg 77A:1845-1852, 1995.
29. Murray DW, Rushton N: Macrophage stimulate bone resorption when they phagocytose particles. J Bone Joint Surg 72B:988-992, 1990.
30. Nakashima Y, Sun D-H, Trindade MCD, et al: Signaling pathways for tumor necrosis factor-α and interleukin-6 expression in human macrophages exposed to titanium-alloy particulate debris in vitro. J Bone Joint Surg 81A:603-615, 1999.
31. Neumann L, Freund KG, Sørenson KH: Long-term results of Charnley total hip replacement. J Bone Joint Surg 76B:245-251, 1994.
32. Older J, Butorac R: Charnley low friction arthroplasty(LFA): A 17-21 year follow-up study. J Bone Joint Surg 74B(Suppl III):251, 1992.
33. Pagnano MW, Hanssen AD, Lewallen DG, et al: The effect of superior placement of the acetabular component on the rate of loosening after total hip arthroplasty. J Bone Joint Surg 78A:1004-1014, 1996.
34. Richeldi L, Sorrentino R, Saltini C: HLA-DPB1 glutamate 69: A genetic marker of beryllium disease. Science 262:242-244, 1993.
35. Santavirta S, Konttinen YT, Bergroth V, et al: Lack of immune response to methyl methacrylate in lymphocyte cultures. Acta Orthop Scand 62:29-32, 1991.
36. Schmalzried TP, Akizuki KH, Fedenko AN, et al: The role of access of joint fluid to bone in periarticular osteolysis. J Bone Joint Surg 79A:447-452, 1997.
37. Schmalzried TP, Jasty M, Harris WH: Periprosthetic bone loss in total hip arthroplasty. J Bone Joint Surg 74A:849-863, 1992.
38. Schmalzried TP, Szuszczewicz ES, Akizuki KH, et al: Factors correlating with long term survival of McKee-Farrar total hip prosthesis. Clin Orthop 329(Suppl):S48-S59, 1996.
39. Schulte KR, Callaghan JJ, Kelley SS, et al: The outcome of Charnley total hip arthroplasty with cement after minimum twenty-year follow-up. J Bone Joint Surg 75A:961-975, 1993.
40. Sinigaglia F: The molecular basis of metal recognition by T cells. J Invest Dermatol 102:398-401, 1994.
41. Sutherland CJ, Wilde AH, Borden LS, et al: A ten-year follow-up of one hundred consecutive Müller curved-stem total hip-replacement arthroplasties. J Bone Joint Surg 64A:970-982, 1982.
42. Svejgaad A, Jersild C, Nielsen LS, et al: HL-A antigens and disease statistical and general considerations. Tissue Antigens 4:95-105, 1974.
43. Svejgaad A, Platz P, Ryder LP, et al: HL-A and disease associations: A survey. Transplant Rev 22:343, 1975.
44. Terasaki PI, Bernoco D, Park MS, et al: Microdroplet testing for HLA-A, -B, -C, and -D antigens. Am J Clin Pathol 69:103-120, 1978.
45. Torchia ME, Klassen RA, Bianco AJ: Total hip arthroplasty with cement in patients less than twenty years old: Long-term results. J Bone Joint Surg 78A:995-1003, 1978.
46. Van Der Vis HM, Aspenberg P, De Kleine R, et al: Short periods of oscillating fluid pressure directed at a titanium-bone interface in rabbits lead to bone lysis. Acta Orthop Scand 69:5-10, 1998.
47. Vollmer J, Weltzien HU, Dormoy A, et al: Functional expression and analysis of a human HLA-DQ restricted, nickel-reactive T cell receptor in mouse hybridoma cells. J Invest Dermatol 113:175-181, 1999.
48. Wooley PH, Fitzgerald Jr RH, Song Z, et al: Proteins bound to polyethylene components in patients who have aseptic loosening after total joint arthroplasty. J Bone Joint Surg 81A:616-623, 1999.
49. Wooley PH, Nasser S, Fitzgerald Jr RH: The immune response to implant materials in humans. Clin Orthop 326:63-70, 1996.
50. Wroblewski BM: 15-21-year results of the Chamley low-friction arthroplasty. Clin Orthop 211:30-35, 1986.
51. Wroblewski BM, Siney PD, Raut VV, et al: Charnley low-friction arthroplasty: 18-26 year results. J Bone Joint Surg 74B(Suppl II):140-141, 1992.
52. Yoder SA, Brand RA, Pederson DR, et al: Total hip acetabular component position affects component loosening rates. Clin Orthop 228:79-87, 1988.
53. Zahiri CA, Schmalzried TP, Ebramzadeh E, et al: Lessons learned from loosening of the McKee-Farrar metal-on-metal total hip replacement. J Arthroplasty 14:326-332, 1999.
54. Zanni MP, Mauri-Hellweg D, Brander C, et al: Characterization of lidocaine specific T cells. J Immunol 158:1139-1148, 1997.